Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas

NCT00006024 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00006024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Temozolomide and CCNU in Pediatric Patients With Newly Diagnosed Incompletely Resected Non-Brainstem High-Grade Gliomas
Lead sponsor
Children's Oncology Group
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2000
Completion date
September 30, 2006
Enrollment
32 (actual)
Sites
235

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, central nervous system tumor